Adial Pharmaceuticals Inc. [NASDAQ: ADIL] jumped around 1.62 points on Tuesday, while shares priced at $3.03 at the close of the session, up 114.89%.
Adial Pharmaceuticals Inc. stock is now 25.73% up from its year-to-date (YTD) trading value. ADIL Stock saw the intraday high of $4.00 and lowest of $1.40 per share. The company’s 52-week high price is 3.17, which means current price is +203.00% above from all time high which was touched on 09/29/20.
Compared to the average trading volume of 819.50K shares, ADIL reached a trading volume of 93195061 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Adial Pharmaceuticals Inc. [ADIL]?
Maxim Group have made an estimate for Adial Pharmaceuticals Inc. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on October 30, 2018. The new note on the price target was released on October 11, 2018, representing the official price target for Adial Pharmaceuticals Inc. stock.
The Average True Range (ATR) for Adial Pharmaceuticals Inc. is set at 0.30 The Price to Book ratio for the last quarter was 3.88, with the Price to Cash per share for the same quarter was set at 0.63.
How has ADIL stock performed recently?
Adial Pharmaceuticals Inc. [ADIL] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 131.30. With this latest performance, ADIL shares gained by 124.44% in over the last four-week period, additionally plugging by 133.08% over the last 6 months – not to mention a rise of 100.66% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ADIL stock in for the last two-week period is set at 86.44, with the RSI for the last a single of trading hit 91.64, and the three-weeks RSI is set at 81.26 for Adial Pharmaceuticals Inc. [ADIL]. The present Moving Average for the last 50 days of trading for this stock 1.49, while it was recorded at 1.63 for the last single week of trading, and 1.59 for the last 200 days.
Adial Pharmaceuticals Inc. [ADIL]: Deeper insight into the fundamentals
Return on Total Capital for ADIL is now -142.38, given the latest momentum, and Return on Invested Capital for the company is -148.36. Return on Equity for this stock declined to -148.36, with Return on Assets sitting at -138.81.
Reflecting on the efficiency of the workforce at the company, Adial Pharmaceuticals Inc. [ADIL] managed to generate an average of -$2,147,857 per employee.Adial Pharmaceuticals Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 13.90 and a Current Ratio set at 13.90.
Earnings analysis for Adial Pharmaceuticals Inc. [ADIL]
With the latest financial reports released by the company, Adial Pharmaceuticals Inc. posted -0.27/share EPS, while the average EPS was predicted by analysts to be reported at -0.18/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -50.00%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for ADIL.
Insider trade positions for Adial Pharmaceuticals Inc. [ADIL]
There are presently around $2 million, or 11.30% of ADIL stock, in the hands of institutional investors. The top three institutional holders of ADIL stocks are: VANGUARD GROUP INC with ownership of 282,909, which is approximately 0% of the company’s market cap and around 5.40% of the total institutional ownership; BLACKROCK INC., holding 205,684 shares of the stock with an approximate value of $0.62 million in ADIL stocks shares; and BANK OF AMERICA CORP /DE/, currently with $0.46 million in ADIL stock with ownership of nearly New of the company’s market capitalization.
Positions in Adial Pharmaceuticals Inc. stocks held by institutional investors increased at the end of September and at the time of the September reporting period, where 3 institutional holders increased their position in Adial Pharmaceuticals Inc. [NASDAQ:ADIL] by around 198,178 shares. Additionally, 3 investors decreased positions by around 16,864 shares, while 7 investors held positions by with 598,212 shares. The mentioned changes placed institutional holdings at 813,254 shares, according to the latest SEC report filing. ADIL stock had 2 new institutional investments in for a total of 192,007 shares, while 2 institutional investors sold positions of 15,251 shares during the same period.